Gaoquan Li

Selective Chk1 inhibitors differentially sensitize p53‐deficient cancer cells to cancer therapeutics

Zehan Chen, Zhan Xiao, Wen‐Zhen Gu et al. · International Journal of Cancer · 2006 · 129 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Design, Synthesis, and Biological Activity of 5,10-Dihydro-dibenzo[<i>b</i>,<i>e</i>][1,4]diazepin-11-one-Based Potent and Selective Chk-1 Inhibitors

Le Wang, Gerard M. Sullivan, Laura A. Hexamer et al. · Journal of Medicinal Chemistry · 2007 · 43 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13

1-(5-Chloro-2-alkoxyphenyl)-3-(5-cyano- pyrazi-2-yl)ureas as Potent and Selective Inhibitors of Chk1 Kinase:  Synthesis, Preliminary SAR, and Biological Activities

Gary T. Wang, Gaoquan Li, Robert A. Mantei et al. · Journal of Medicinal Chemistry · 2005 · 42 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Synthesis and biological evaluation of 1-(2,4,5-trisubstituted phenyl)-3-(5-cyanopyrazin-2-yl)ureas as potent Chk1 kinase inhibitors

Gaoquan Li, Lisa Hasvold, Zhi‐Fu Tao et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 32 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13

Alkylated Trimethylene-Bridged Bis(<i>p</i>-Phenylenediamines)

Stephen F. Nelsen, Gaoquan Li, Kevin P. Schultz et al. · Journal of the American Chemical Society · 2008 · 31 citations

Natural Sciences, Chemistry, Inorganic Chemistry +9